Status | Study |
Completed |
Study Name: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Condition: Symptoms of Carcinoid Syndrome Date: 2010-04-12 Interventions: Drug: Low Dose LX1606 - Day 1 (start) |
Terminated |
Study Name: Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2009-11-24 Interventions: Drug: BIM 23A760 BIM 23A760 is a solution at a concentration of 5 mg/mL ready for subcutaneous injection |
Completed |
Study Name: Azilect + Antidepressant Chart Review Condition: Serotonin Syndrome Date: 2009-08-06 Interventions: Drug: Group R+AD Rasagiline + Antidepressant |
Terminated |
Study Name: Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2009-04-20 Interventions: Drug: Octreotide short acting octreotide |
Completed |
Study Name: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy Condition: Carcinoid Syndrome Date: 2009-02-25 Interventions: Drug: Low Dose LX1606 Part 1 A |
Completed |
Study Name: Gastrointestinal Motility in Patients With Neuroendocrine Tumors Condition: Neuroendocrine Tumor Date: 2008-11-11 Interventions: Device: Magnetic Tracking System (MTS) and radio-opaque markers MTS: A small magnetic pill (6x15mm) is s |
Completed |
Study Name: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2008-10-15 Interventions: Drug: Lanreotide deep s.c. inj |
Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Date: 2008-01-25 Interventions: Drug: capecitabine Drug: cisplatin |
Completed |
Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Neoplast Date: 2007-01-25 Interventions: Drug: AMG 706 AMG 706 was admi |
Completed |
Study Name: Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor Condition: Carcinoid Tumor Malignant Carcinoid Syndrome Date: 2006-12-13 Interventions: Drug: Octreotide Octreotide 30 |